Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of preventing or treating skin necroptosis disease comprising RIP3-MLKL pathway blocker

Method of preventing or treating skin necroptosis disease comprising RIP3-MLKL pathway blocker

US Patent 10004736 · Granted Jun 26, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Security analysis system and method based on negative testing for protocol imple2025
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2025
Composition for treating or preventing colitis by NAMPT metabolic regulation2025
Early detection marker for degenerative osteoarthritis with TRIM24-RIP3 axis2024
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2024
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2023
Composition for anticancer adjuvant comprising RIP3 expression promoter as activ2021
Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL 2020
Anticancer adjuvant composition containing RIP3 expression promoter as active in2019
Gut flora-derived extracellular vesicles, and method for searching for a disease2016
Gut flora-derived extracellular vesicles, and method for searching for a disease2015
Object detection device and system2013